Ionis Pharmaceuticals Inc (IONS) — Cash Flow Quality Index

Latest as of June 2025: 1.22x

Ionis Pharmaceuticals Inc (IONS) has a Cash Flow Quality Index of 1.22x as of June 2025. Operating cash flow of $151.34 Million exceeds net income of $123.55 Million, indicating high earnings quality where cash backs reported profits. Explore Ionis Pharmaceuticals Inc (IONS) long-term investment share to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

1.22x
Operating CF / Net Income

Operating Cash Flow

$151.34 Million
USD

Net Income

$123.55 Million
USD

Data as of

Jun 2025
Most recent filing

Ionis Pharmaceuticals Inc Cash Flow Quality Index (2009–2019)

Historical Cash Flow Quality Index for Ionis Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check IONS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for Ionis Pharmaceuticals Inc (2009–2019)

Year-by-year earnings quality comparison for Ionis Pharmaceuticals Inc. For live market cap and the full company financial profile, see market cap of Ionis Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2019 1.14x $345.72 Million $303.26 Million ▼ -59.3%
2018 2.80x $602.89 Million $214.99 Million ▲ +489.6%
2009 -0.72x $-108.44 Million $150.67 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.